Sulfinpyrazone kinetics after intravenous and oral administration
暂无分享,去创建一个
Sulfinpyrazone kinetics has been investigated after intravenous and oral doses. They may be described by a 3‐compartment open model. In the body about half the drug is in the plasma or in interstitial fluids, which are readily equilibrated with plasma. Most of the rest is in an extravascular compartment, from which it easily diffuses back to the plasma. About 3% of the dose is still in the body after 24 hr and is located mainly in a deep compartment. After oral administration, sulfinpyrazone is quickly absorbed, largely from the stomach.
[1] L. Endrenyi,et al. Comparative drug elimination capacity in man‐glutethimide, amobarbital, antipyrine, and sulfinpyrazone , 1973, Clinical pharmacology and therapeutics.
[2] B. Brodie,et al. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. , 1957, The Journal of pharmacology and experimental therapeutics.
[3] Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. , 1978, The New England journal of medicine.